Blog
Looking for a Growth Stock? 3 Reasons Why PG&E (PCG) is a Solid Choice
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great
Flexsteel (FLXS) is an Incredible Growth Stock: 3 Reasons Why
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Robinhood Gets In-Principle Approval From MAS for Singapore Launch
Robinhood Markets, Inc. HOOD has taken a meaningful step in its global growth strategy. The company received in-principle approval from the Monetary Authority of Singapore (MAS) to launch brokerage
Iran War Fails to Dampen China Q1 Industrial Profit Jump: ETFs at Play
According to data from China’s National Bureau of Statistics, the nation’s industrial profits jumped 15.8% year over year in March 2026, accelerating from the 15.2% surge witnessed in the first two
Baxter Q1 Preview: Will Operational Headwinds Weigh on Results Again?
Baxter International Inc. BAX is scheduled to release first-quarter 2026 results on April 30, before the opening bell. In the last reported quarter, the company’s earnings missed the Zacks Consensus
Is Cirrus Logic's Product Mix Boosting Its Performance?
Cirrus Logic, Inc. CRUS continues to benefit from a favorable product mix that is driving growth. The company is seeing rising momentum in the laptop market, alongside increasing design activity
IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts
ImmunityBio IBRX is moving from a U.S.-led launch to a broader international rollout. Authorizations now span the United States, the United Kingdom, the European Union, Saudi Arabia, and Macau
Is IBRX Priced for Perfection at Nearly 28x Forward Sales?
ImmunityBio IBRX has delivered a stunning rerating in 2026. After a move like this, investors often stop debating the story and start debating the price. That shift matters because valuation can
IBRX: What Anktiva's Bladder Data Says About 2026 Sales
ImmunityBio IBRX enters 2026 with a commercial story that is unusually concentrated. Anktiva is the company’s first marketed product, and it is already the clear topline driver.
What matters now is
SENS Launches Eversense 365, World's Only One-Year CGM in Europe
Senseonics SENS recently announced the European launch of its groundbreaking Eversense 365 CGM system, the world’s first continuous glucose monitoring (CGM) system designed to last an entire year
South Korea ETF (EWY) Hits New 52-Week High
iShares MSCI South Korea ETF EWY is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 183.68% from its 52-week low price of $55.33 per share.
Domino's Q1 Earnings & Revenues Miss Estimates, Stock Down
Domino's Pizza, Inc. DPZ reported first-quarter fiscal 2026 results, with earnings missing the Zacks Consensus Estimate and decreasing on a year-over-year basis. However, total revenues also missed
Oil to Stay Elevated Above Pre-Conflict Levels: Energy ETFs to Benefit
Brent crude, the global benchmark, climbed above $106 per barrel, gaining nearly 7% over the past five days as oil rose this Monday as stalled Iran talks kept shipment flows through the Strait of
Earnings Estimates Rising for Gorman-Rupp (GRC): Will It Gain?
Gorman-Rupp (GRC) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with
Surging Earnings Estimates Signal Upside for STMicroelectronics (STM) Stock
STMicroelectronics (STM) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue
Can Texas Instruments (TXN) Run Higher on Rising Earnings Estimates?
Texas Instruments (TXN) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue
Earnings Estimates Moving Higher for Docebo (DCBO): Time to Buy?
Investors might want to bet on Docebo Inc. (DCBO), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum
Why Cass (CASS) Might be Well Poised for a Surge
Investors might want to bet on Cass Information Systems (CASS), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price
Eni Stock Rises 2.83% Post Unlocking 5Tcf Gas Potential in Kutei Basin
Eni S.p.A. E on April 20, 2026 announced a significant gas discovery at the Geliga-1 exploration well in the Kutei Basin, offshore Indonesia. Following the announcement, E shares rose 2.83% to
Bread Financial Q1 Earnings Beat Estimates on Higher Credit Sales
Bread Financial Holdings, Inc. BFH reported first-quarter 2026 operating income of $4.18 per share, outperforming the Zacks Consensus Estimate by 39.3%. The bottom line rose 49% year over year.
TT Gears Up to Report Q1 Earnings: What's in the Cards?
Trane Technologies plc TT is set to report first-quarter 2026 earnings on April 30, before the opening bell.
The company’s earnings surprise history has been impressive. It surpassed the Zacks
Newell Brands' Q1 Earnings Approaching: What's in Store for the Stock?
Newell Brands Inc. NWL is expected to register a year-over-year decline in the top and bottom lines when it reports first-quarter 2026 results on May 1, before the opening bell. The Zacks Consensus
NVS SMA Drug Gets CHMP Backing, Malaria Drug Wins WHO Prequalification
Novartis NVS announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending marketing authorization for
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings?
Amazon AMZN is scheduled to report first-quarter 2026 results on April 29.For the first quarter, the company anticipates net sales between $173.5 billion and $178.5 billion, implying 11% to 15%


